[Federal Register Volume 60, Number 13 (Friday, January 20, 1995)]
[Notices]
[Page 4169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-1466]



[[Page 4169]]

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made final findings of scientific misconduct in the following 
case:
    David F. Eierman, Ph.D., University of North Carolina at Chapel 
Hill: The Division of Research Investigations (DRI) of the Office of 
Research Integrity (ORI) reviewed an investigation conducted by the 
University of North Carolina at Chapel Hill into possible scientific 
misconduct on the part of Dr. Eierman while a research assistant at the 
University of North Carolina. Based in part on Dr. Eierman's admission, 
the University concluded that he committed scientific misconduct by 
falsifying or fabricating data in biomedical research supported by two 
Public Health Service grants. The ORI accepted the University's 
conclusions and found that Dr. Eierman engaged in scientific 
misconduct.
    Dr. Eierman has fully cooperated with the University of North 
Carolina and ORI in this matter and has signed a Voluntary Exclusion 
Agreement under which he has agreed to be excluded from support under 
Federal grants, contracts, and cooperative agreements for a three-year 
period beginning December 12, 1994, and ending December 11, 1997, and 
from service on PHS advisory committees, boards, or peer review groups 
for the same period. ORI notes that Dr. Eierman's cooperation in 
resolving this matter indicates that he has accepted responsibility for 
his actions, and this is regarded as a positive factor that was taken 
into consideration in negotiating the Voluntary Exclusion Agreement. 
The fabricated and falsified data were reported in two manuscripts that 
were never published and in Figure 3 of ``1 and 
2 Integrin Subunit Regulation of the Monocyte 
Inflammatory Response,'' Cellular and Cytokine Networks in Tissue 
Immunity (M. Meltzer, and A. Mantovani, Eds.). (1991). New York: Wiley-
Liss.

FOR FURTHER INFORMATION CONTACT: Director. Division of Research 
Investigations, Office of Research Integrity, 301-443-5330.
Lyle W. Bivens, Ph.D.
Director, Office of Research Integrity.
[FR Doc. 95-1466 Filed 1-19-95; 8:45 am]
BILLING CODE 4160-17-P-M